Evidence map›Paper›PMID 25661243›Full record

ArticleHuman pathology2015

Well-differentiated hepatocellular neoplasm of uncertain malignant potential.

Charles Balabaud, Paulette Bioulac-Sage, Linda Ferrell, Sanjay Kakar, Valérie Paradis, Alberto Quaglia, Christine Sempoux, Swan Thung, Jessica Zucman-Rossi

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Human pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Malignant transformation of hepatocellular adenoma.JHEP reports : innovation in hepatology · 2022
    Article
  4. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Article
  5. Article
  6. A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection.Liver international : official journal of the International Association for the Study of the Liver · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Charles BalabaudInserm U 1053, Université de Bordeaux, 33076 Bordeaux Cedex, France. Electronic address: charles.balabaud@u-bordeaux2.fr.
Paulette Bioulac-SageUniversité de Bordeaux, 33076 Bordeaux Cedex, France; Service de Pathologie, Hôpital Pellegrin CHU Bordeaux, 33076 Bordeaux Cedex, France.
Linda FerrellDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94143-0102.
Sanjay KakarDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94143-0102.
Valérie ParadisDepartment of Parhology, Beaujon Hospital, 92110 Clichy, France.
Alberto QuagliaInstitute of Liver Studies, King's College Hospital, London, United Kingdom.
Christine SempouxInstitut de Pathologie, 1011 Lausanne, Switzerland.
Swan ThungDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Jessica Zucman-RossiInserm U1162, Université Paris Descartes, 75010 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenoma, Liver Cellbeta CateninCarcinoma, HepatocellularFemaleHumansLiver NeoplasmsMalebeta Catenin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.